Adagrasib is a highly selective, orally administered KRAS G12C inhibitor used for the treatment of patients with advanced cancers harboring a KRAS G12C mutation.
Authentic
Guarantee
Fast Delivery
Privacy Copyright2024@ BIGBEAR All right reserved BIGBEAR



